TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study.
Yuan Y, He W, Yang Z, Qiu J, Huang Z, Shi Y, Lin Z, Zheng Y, Chen M, Lau WY, Li B, Yuan Y.
Int J Surg. 2023 May 1;109(5):1222-1230. doi: 10.1097/JS9.0000000000000256.
PMID:37026861
Better surgical treatment method for hepatocellular carcinoma with portal vein tumor thrombus.
Peng SY, Wang XA, Huang CY, Li JT, Hong DF, Wang YF, Xu B.
World J Gastroenterol. 2018 Oct 28;24(40):4527-4535. doi: 10.3748/wjg.v24.i40.4527.
Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus: A Systematic Review and Meta-Analysis.
Deng J, Liao Z, Gao J.
Curr Oncol. 2023 Jan 16;30(1):1243-1254. doi: 10.3390/curroncol30010096.
PMID:36661745
Portal vein tumor thrombosis in hepatocellular carcinoma: molecular mechanism and therapy.
Zhou XH, Li JR, Zheng TH, Chen H, Cai C, Ye SL, Gao B, Xue TC.